
24 Mar 2016 --- OmniActive will present a poster on their OmniLean Salacia Extract Trial in Healthy Human Subjects at Experimental Biology 2016.
Vijaya Juturu Ph.D., F.A.C.N., Senior Manager of Global Scientific and Clinical Affairs, OmniActive Health Technologies Inc. will present findings from the study: "Salacia Extract Improves Post-Prandial Glucose and Insulin Response: A Randomized Double-Blind, Placebo-Controlled, Crossover Study in Healthy Volunteers" at the Experimental Biology Conference, April 2-6 in San Diego, California, USA.
OmniLean provides a comprehensive approach to achieving multiple objectives of healthy metabolism including healthy carbohydrate metabolism, fat metabolism, heart health and weight management in one convenient, low dose ingredient from a traceable, reliable supply chain.
Upcoming webinars

Introducing LifeChews® and the Next Generation of Plant-based Supplements
Sirio

Why ARA & DHA matter: Key lipids shaping infant development
dsm-firmenich

Innovating Skin Supplements: New Folate Evidence for Beauty from Within
Gnosis by Lesaffre










